<DOC>
	<DOC>NCT00294294</DOC>
	<brief_summary>The purpose of the study is to determine whether prophylactic antipyretic treatment after vaccination with Prevenar and a concomitant hexavalent DTPa combination vaccine reduces the rate of febrile reactions.</brief_summary>
	<brief_title>Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa</brief_title>
	<detailed_description />
	<mesh_term>Fever</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy infants age 55 to 112 days Subject's parents/legal guardians provide written informed consent Prematurely born subjects &lt; 37 weeks gestation Known or suspected disease of immune system Known or suspected hypersensitivity to any vaccine or vaccine component</criteria>
	<gender>All</gender>
	<minimum_age>56 Days</minimum_age>
	<maximum_age>112 Days</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>vaccine</keyword>
	<keyword>infant</keyword>
</DOC>